Matching codes
Official code-level notes2
- Excludes 1
- presence of other part of cardiac pacemaker (Z95.0)
- Excludes 2
- presence of prosthetic and other devices (Z95.1-Z95.5, Z95.811-Z97)
Official code-level notes2
- Inclusion terms
- Encounter for adjustment and management of automatic implantable cardiac defibrillator with synchronous cardiac pacemaker
- Inclusion terms
- Encounter for adjustment and management of cardiac resynchronization therapy defibrillator (CRT-D)
Official code-level notes6
- Inclusion terms
- Encounter for adjustment and management of brain neurostimulator
- Inclusion terms
- Encounter for adjustment and management of gastric neurostimulator
- Inclusion terms
- Encounter for adjustment and management of peripheral nerve neurostimulator
- Inclusion terms
- Encounter for adjustment and management of sacral nerve neurostimulator
- Inclusion terms
- Encounter for adjustment and management of spinal cord neurostimulator
- Inclusion terms
- Encounter for adjustment and management of vagus nerve neurostimulator
Official code-level notes2
- Excludes 2
- encounter for adjustment and management of implanted nervous system device (Z45.4-)
- Excludes 2
- encounter for adjustment and management of implanted visual substitution device (Z45.31)
Official code-level notes1
- Excludes 2
- long term (current) use of aspirin (Z79.82)
Official code-level notes1
- Inclusion terms
- Long term (current) use of birth control pill or patch
Official code-level notes3
- Excludes 2
- long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
- Excludes 2
- long term (current) use of oral antidiabetic drugs (Z79.84)
- Excludes 2
- long term (current) use of oral hypoglycemic drugs (Z79.84)
Official code-level notes4
- Inclusion terms
- Long term (current) use of apremilast
- Inclusion terms
- Long term (current) use of immunomodulatory imide drug
- Inclusion terms
- Long term (current) use of lenalidomide
- Inclusion terms
- Long term (current) use of pomalidomide
Official code-level notes4
- Inclusion terms
- Long term (current) use of adalimumab
- Inclusion terms
- Long term (current) use of etanercept
- Inclusion terms
- Long term (current) use of infliximab
- Inclusion terms
- Long term (current) use of monoclonal antibodies
Official code-level notes2
- Inclusion terms
- Long term (current) use of cyclosporine
- Inclusion terms
- Long term (current) use of tacrolimus
Official code-level notes1
- Inclusion terms
- Long term (current) use of tofacitinib
Official code-level notes1
- Inclusion terms
- Long term (current) use of sirolimus
Official code-level notes3
- Inclusion terms
- Long term (current) use of azathioprine
- Inclusion terms
- Long term (current) use of mycophenolate
- Inclusion terms
- Long term (current) use of purine synthesis (IMDH) inhibitors
Official code-level notes3
- Inclusion terms
- Long term (current) use of chlorambucil
- Inclusion terms
- Long term (current) use of cisplatin
- Inclusion terms
- Long term (current) use of cyclophosphamide
Official code-level notes4
- Inclusion terms
- Long term (current) use of 5-fluorouracil
- Inclusion terms
- Long term (current) use of 6-mercaptopurine
- Inclusion terms
- Long term (current) use of cytarabine
- Inclusion terms
- Long term (current) use of methotrexate
Official code-level notes3
- Inclusion terms
- Long term (current) use of bleomycin
- Inclusion terms
- Long term (current) use of doxorubicin
- Inclusion terms
- Long term (current) use of mitomycin C
Official code-level notes4
- Inclusion terms
- Long term (current) use of paclitaxel
- Inclusion terms
- Long term (current) use of plant alkaloids
- Inclusion terms
- Long term (current) use of vinblastine
- Inclusion terms
- Long term (current) use of vincristine
Official code-level notes3
- Inclusion terms
- Long term (current) use of etoposide
- Inclusion terms
- Long term (current) use of irinotecan
- Inclusion terms
- Long term (current) use of topotecan
Official code-level notes1
- Inclusion terms
- Long term (current) use of hydroxyurea